By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


XBiotech USA, Inc. 

8201 E Riverside Drive
Building 4, Suite 100
Austin  Texas  78744  U.S.A.
Phone: 512-386-5107 Fax: n/a


Start Up

Company News
XBiotech USA (XBIT) Secures Approval From Data Safety Monitoring Board To Continue Phase III Registration Study In Europe For Its Novel Cancer Immunotherapy 5/18/2015 7:38:39 AM
XBiotech USA (XBIT) Enrolls First Patient Under Revised Protocol For U.S. Phase III Registration Study Using Xilonix For Treatment Of Metastatic Colorectal Cancer 4/29/2015 7:25:35 AM
XBiotech USA (XBIT) Closes IPO 4/17/2015 2:47:10 PM
XBiotech USA, Inc. Announces Pricing Of Initial Public Offering 4/15/2015 3:37:50 PM
XBiotech USA, Inc. Announces Phase II Psoriasis Study Results in JAMA Dermatology 3/5/2015 6:51:18 AM
Austin Biotech Firm XBiotech USA, Inc. Begins Construction On $200 Million Campus 9/25/2014 7:32:18 AM
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results 9/2/2014 1:11:00 PM
XBiotech USA, Inc. Enrolls First Patient In Phase III European Registration Study Using Xilonix™ For Treatment Of Colorectal Cancer 8/4/2014 6:37:40 AM
XBiotech USA, Inc. Announces Phase I/II Study Results In Lancet 4/17/2014 12:26:11 PM
XBiotech USA, Inc. Welcomes Addition Of Senior Vice President Corporate Development & General Counsel 4/16/2014 6:24:48 AM